IONIS Investigative Site

San Francisco, California 94143

0 studies enrolling now · 4 studies all time

What they study most

Familial Chylomicronemia Syndrome, Geographic Atrophy, Hyperlipoproteinemia Type 1, Hypertriglyceridemia, Lipoprotein Lipase Deficiency, Macular Degeneration

Studies at this site

• GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Completed
• The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome — Completed
• The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia — Completed
• The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome — Completed